---
figid: PMC11701794__FSB2-39-e70284-g004
figtitle: CEMIP affects the PI3K/AKT, EGFR, and Wnt/B‐catenin signaling pathways,
  which contribute to cancer progression by promoting cancer cell growth, angiogenesis,
  and proliferation, while also inhibiting cell death
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11701794
filename: FSB2-39-e70284-g004.jpg
figlink: /pmc/articles/PMC11701794/figure/F2/
number: F2
caption: CEMIP affects the PI3K/AKT, EGFR, and Wnt/β‐catenin signaling pathways, which
  contribute to cancer progression by promoting cancer cell growth, angiogenesis,
  and proliferation, while also inhibiting cell death.18, 43 CEMIP inhibits semaphorin
  3A‐ and plexin A2‐dependent apoptosis, activates the RAS/MEK1/ERK1/2 pathway, and
  promotes EMT.14 CEMIP also activates the ITPR3/CaMK2/NRF2/SLC7A11 pathway, allowing
  cancer cells to escape ferroptosis.40 CEMIP enhances PI3K activity, leading to Akt
  phosphorylation, which in turn promotes cell growth, enhances protein synthesis,
  and prevents cell apoptosis.16, 35 This image was created with BioRender (https://biorender.com/)
papertitle: 'The crucial role of CEMIP in cancer metastasis: Mechanistic insights
  and clinical implications'
reftext: Yeo Gyeong Ko, et al. FASEB J. 2025 Jan 06;39(1).
year: '2025'
doi: 10.1096/fj.202402522R
journal_title: The FASEB Journal
journal_nlm_ta: FASEB J
publisher_name: .na.character
keywords: Anoikis | cancer metastasis | CEMIP | EMT | ferroptosis | hyaluronan | hyaluronidase
  | KIAA1199 | premetastatic niche formation | tumor microenvironment
automl_pathway: 0.9599151
figid_alias: PMC11701794__F2
figtype: Figure
redirect_from: /figures/PMC11701794__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11701794__FSB2-39-e70284-g004.html
  '@type': Dataset
  description: CEMIP affects the PI3K/AKT, EGFR, and Wnt/β‐catenin signaling pathways,
    which contribute to cancer progression by promoting cancer cell growth, angiogenesis,
    and proliferation, while also inhibiting cell death.18, 43 CEMIP inhibits semaphorin
    3A‐ and plexin A2‐dependent apoptosis, activates the RAS/MEK1/ERK1/2 pathway,
    and promotes EMT.14 CEMIP also activates the ITPR3/CaMK2/NRF2/SLC7A11 pathway,
    allowing cancer cells to escape ferroptosis.40 CEMIP enhances PI3K activity, leading
    to Akt phosphorylation, which in turn promotes cell growth, enhances protein synthesis,
    and prevents cell apoptosis.16, 35 This image was created with BioRender (https://biorender.com/)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - RPTOR
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ITPR3
  - ITPR1
  - ITPR2
  - CEMIP
  - GABPA
  - NFE2L2
  - CAMK2B
  - CAMK2A
  - CAMK2D
  - CAMK2G
  - HNF4A
  - SLC7A11
  - SEMA3A
  - GPR162
  - EGFR
  - MAPK3
  - MAPK1
  - ITK
  - SLC22A3
  - ASCL2
  - MYC
  - PPARD
  - EGF
  - Cancer
---
